Serum a(l + 3>L-fucosyltransferase activity was measured in 58 patients with lung cancer, 27 benign diseases, and in 100 healthy controls. The levels of enzyme activity were significantly higher in the sera of patients with cancer when compared to those in benign diseases and healthy controls. The e
Cancer-associated elevation of α(1 → 3)-l-fucosyltransferase activity in human serum
✍ Scribed by Shin Yazawa; Ragupathy Madiyalakan; Khushi L. Matta; Hideaki Izawa; Takayuki Asao; Ken Furukawa
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 472 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
GDP-L-Fuc:N-acetyl--D-glucosaminide ␣1-6 fucosyltransferase (␣1-6FucT) catalyzes the transfer of a fucosyl residue from GDP-fucose to the asparagine-linked GlcNAc residue of complex N-glycans via ␣1-6 linkage. These oligosaccharide structures are essential for the attachment of polysialic acid to t
BACKGROUND. Several investigators have revealed that urokinase-type plasminogen activator (uPA) and its receptor (uPAR) are overexpressed in serum as well as in tumor tissues in patients with various types of cancer. In this study, we examined whether the serum levels of uPA and uPAR could be used a
The p53 null HL-60 cell line was transfected with plasmids coding for either the wild-type p53 or mutant p53 gene. The stable expression of wild-type p53 resulted in a significant increase in sensitivity to the topoisomerase II poisons etoposide and doxorubicin, but not to the topoisomerase II inhib